Topical Drug Delivery Partnering 2009-2014 provides understanding and
access to the topical drug delivery partnering deals and agreements
entered into by the world's leading healthcare companies.

The report provides a detailed understanding and analysis of how and why
companies enter topical drug delivery partnering deals. The majority of
deals are discovery or development stage whereby the licensee obtains a
right or an option right to license the licensors topical drug delivery
technology. These deals tend to be multicomponent, starting with
collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated
deals terms provides critical insight into the negotiation process in
terms of what you can expect to achieve during the negotiation of terms.
Whilst many smaller companies will be seeking details of the payments
clauses, the devil is in the detail in terms of how payments are
triggered - contract documents provide this insight where press releases
do not.

This data driven report includes:

Trends in topical drug delivery dealmaking in the biopharma industry
since 2009

Access to summary headline, upfront, milestone and royalty data

Access to over 190 topical drug delivery contract documents

The leading topical drug delivery deals by value since 2009

In Topical Drug Delivery Partnering 2009-2014, the available deals
are listed by: